Neumora Therapeutics, Inc. Increase (Decrease) in Other Operating Assets and Liabilities, Net
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-08-14
- Neumora Therapeutics, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was $0.00.
- Neumora Therapeutics, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was -$1.00K.
- Neumora Therapeutics, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2024-12-31 was $0.00.
- Neumora Therapeutics, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2024-09-30 was $0.00.
- Neumora Therapeutics, Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was $53.00K.
- Neumora Therapeutics, Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was $0.00.
- Neumora Therapeutics, Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was -$1.37M.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.00K derived: sum of 2 quarters · filed 2026-03-30 | $53.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $53.00K 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $54.00K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-06 | |||
| 2022-12-31 | $6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$1.37M 10-K · filed 2025-03-03 | ||
| 2022-09-30 | -$7.62M 10-Q · filed 2023-11-01 |